Table 1. Scientific opportunities for the Precision Medicine Initiativea.
| Discovery of methods to measure disease risk based on environmental exposure, genetics and interactions between the two |
| Identification of genetic contributors to differences in drug response |
| Discovery of disease biomarkers associated with increased or decreased risk for developing common diseases |
| Use of mobile health (mHealth) devices to evaluate connections between health outcomes and activity, physiology and environmental exposures |
| Development of new classification of diseases |
| Empowerment of study participants with “data and information to improve their own health.” |
| Creation of a platform to enable clinical trials of targeted therapies |
a. Adapted from the Precision Medicine Initiative web site1